janmacek
☆    

Czech Republic,
2016-05-11 15:09
(2900 d 00:53 ago)

Posting: # 16293
Views: 2,145
 

 Method validation for each species [Bioanalytics]

Post reply
Dear all,

we are planning validation of a bioanalytical method for the determination of a drug candidate in plasma. This method should be used for the analysis of samples from various species (rat, mouse, dog, etc.). The European Guideline states that full validation should be performed for each species and matrix concerned, while the FDA guideline states that partial validation is required for the change of species within matrix.

What is your experience with this topic? Is the approach really different in Europe and US?

With best regards,

Jan
 
UA Flag
Activity
 Admin contact
22,987 posts in 4,824 threads, 1,665 registered users;
86 visitors (0 registered, 86 guests [including 7 identified bots]).
Forum time: 16:03 CEST (Europe/Vienna)

The only way to comprehend what mathematicians mean by Infinity
is to contemplate the extent of human stupidity.    Voltaire

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5